Paris, France

Hifibio Sas


USPTO Granted Patents = 4


Trademarks = 1

Forward Citations = 1

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Marcel Reichen (3 out of 3 patents)

silverMedal Arnaud Reitz (2 out of 2 patents)

bronzeMedal Sami Ellouze (2 out of 3 patents)

4.  Raphael Clément Li-Ming Doineau (2 out of 4 patents)

5.  Bingqing Shen (1 out of 1 patent)

6.  Annabelle Gerard (1 out of 3 patents)

7.  Annabelle Patricia Veronique Gérard (1 out of 1 patent)

8.  Vera Menrath (1 out of 2 patents)

9.  Andrew David Griffiths (5 patents)

10.  Annabelle Patricia Véronique Gerard (0 patent)

11.  Kévin Armand Grosselin (1 patent)

12.  Annabelle Patricia Veronique Gérard (0 patent)

13.  Céline Victoire Delphine Marie Vallot (0 patent)


4 patents:

Company Overview
Hifibio Sas is a biotechnology company focused on the discovery and development of innovative cancer therapies. By leveraging cutting-edge technology and a deep understanding of cancer biology, Hifibio aims to create novel treatments that address unmet medical needs and improve patient outcomes. Their platform combines expertise in immunology, genomics, and bioinformatics to identify promising drug targets and develop targeted therapies. Hifibio is committed to advancing science and transforming the landscape of cancer treatment.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#640 in Paris

#3,354 in France

Paris, FR
Paris, France
Forward Citations = 1

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hifibio Sas. Retrieved from https://idiyas.com/company/hifibio-sas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…